Roivant Sciences Ltd (ROIV)

Payables turnover

Mar 31, 2024 Mar 31, 2023 Mar 31, 2022
Cost of revenue US$ in thousands 687,443 600,960 775,033
Payables US$ in thousands 53,225 37,830 34,583
Payables turnover 12.92 15.89 22.41

March 31, 2024 calculation

Payables turnover = Cost of revenue ÷ Payables
= $687,443K ÷ $53,225K
= 12.92

The payables turnover ratio for Roivant Sciences Ltd has shown a downward trend over the past three fiscal years. In particular, the payables turnover ratio decreased from 22.41 in March 2022 to 15.89 in March 2023, and further decreased to 12.92 in March 2024. This indicates that the company took longer to pay its creditors in the most recent fiscal year compared to the prior years. A decreasing payables turnover ratio could suggest potential liquidity issues, inefficiencies in managing payables, or changes in the company's payment terms with suppliers. Further investigation into the reasons behind this trend and its impact on the company's financial health and cash flow management would be beneficial.


Peer comparison

Mar 31, 2024